In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...
A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way to measure the effect ...
Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...
The drug was renamed simufilam in August of 2020, and in preliminary studies, patients started showing improvement after just a month — “extraordinary for any Alzheimer’s trial,” writes ...
A revolutionary new drug called RI-AG03 has demonstrated remarkable potential in preventing the devastating effects of Alzheimer‘s disease. The medication specifically targets tau proteins ...
Alzheimer's disease, a major health issue, may benefit from common drugs and early interventions. In a new thesis from the Department of Medical Epidemiology and Biostatistics, Ph.D. student Bowen ...
A complementary drug to combat Alzheimer’s disease could target a specific part of the nerve cell protein tau. This is the finding of research from the University of Gothenburg, which also ...
New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study ...
Bishop asked about upcoming events. Missling outlined the anticipated schizophrenia trial readout for ANAVEX 3-71 in the first half of 2025, the detailed ATTENTION-AD data presentation in April, and ...
News Medical on MSN4d
Breakthrough discovery on tau protein opens new paths for Alzheimer’s drug developmentA complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback